U.S. Stem Cell, Inc.【USRM】Balance sheet

Market cap

$64.15K

P/E ratio

	2011/12	2015/12	2016/12	2017/12	2018/12	2019/12	2021/12	2022/12
Cash and cash equivalents	36,828	58,372	270,720	986,799	1	-	39,393	5,133
Total cash & short-term investments	36,828	58,372	270,720	986,799	1	-	39,393	5,133
Accounts receivable, net	3,495	35,032	16,025	42,959	18,035	-	1,213	4,332
Inventories	63,702	17,406	42,218	70,364	93,215	-	393	980
Total current assets	153,853	115,642	328,963	1	2	-	50,999	68,039
Property, plant and equipment, net	15,476	14,172	20,969	449,747	242,615	-	-	-
Total non-current assets	114,640	113,471	98,673	494,833	310,565	-	-	-
Total assets	268,493	229,113	427,636	2	2	-	50,999	68,039
Accounts payable	2	2	1	1	1	-	1	2
Long-term debt, current	-	71,136	3,551	-	-	-	-	-
Total current liabilities	12	6	6	6	6	-	12	14
Long-term debt, non-current	-	1	1	1	1	-	-	-
Total non-current liabilities	-	2	2	2	3	-	778,560	735,544
Total liabilities	12	8	8	9	9	-	13	15
Common stock and paid-in capital	99	115	116	121	123	-	127	128
Retained earnings	-	-122,076,374	-124,146,760	-127,628,251	-129,788,678	-	-139,801,924	-142,517,282
Stockholders' equity	-12,010,477	-7,721,446	-8,018,644	-7,100,317	-6,882,210	-	-12,766,336	-14,745,396
Total debt	-	1	1	1	1	-	-	-
Net debt	-	1	961,521	241,891	-58,567	-	-	-
D/E ratio (%)	-	-16.9	-15.4	-17.3	-18.9	-	-	-
Working capital						-